Related Experiment Video
Updated: Apr 5, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Skin Carotenoid Response to a High-Carotenoid Juice in Children: A Randomized Clinical Trial
Insights
Consuming carotenoid-rich juice significantly boosted skin carotenoid levels in children aged 5-17 over 8 weeks. This juice provides carotenoids comparable to cooked carrots, enhancing nutritional status.
Area of Science:
- Nutrition Science
- Dermatology
- Pediatrics
Background:
- Previous research indicates increased serum carotenoid levels in children following carotenoid supplementation.
- This study investigates the dose-response relationship between carotenoid intake and changes in skin carotenoid status in children.
Purpose of the Study:
- To determine the effect of a specific dose of carotenoid-rich juice on skin carotenoid status in children.
- To establish a dose-response relationship for carotenoid intake and its impact on skin carotenoid levels.
Main Methods:
- A randomized controlled trial involving 58 children aged 5-17 years.
- Participants were assigned to high-dose, low-dose carotenoid juice, or placebo groups for 8 weeks.
- Skin carotenoid levels were measured bi-weekly using resonance Raman spectroscopy.
Main Results:
- Both high-dose and low-dose groups showed significant increases in skin carotenoid status (P <0.001).
- Significant changes were observed as early as Week 2 in the supplemented groups.
- The placebo group exhibited no statistically significant change in skin carotenoid levels.
Conclusions:
- Daily consumption of 30-120 mL of carotenoid-rich juice effectively increases skin carotenoid status in children.
- The carotenoid dosage in the juice is equivalent to 23-92g of cooked carrots.
- This intervention offers a practical method to improve carotenoid levels in pediatric populations.
Background:
Previous studies have shown an increase in serum carotenoid status among children when fed carotenoids. This study looked at the effect and dose-response of a known amount of carotenoid consumption on change in skin carotenoid status among children.
Methods:
Participants were children aged 5 to 17 years from Cache County, UT (n=58). Children were randomly assigned to one of three groups: high (n=18) or low (n=18) dose of a carotenoid-rich juice (2.75 mg carotenoids/30 mL juice), or placebo juice (n=22). Children were asked to drink an assigned dose of the juice (30 to 120 mL/day) based on the weight of the child and group assignment, every day for 8 weeks. Skin carotenoids were measured every 2 weeks by resonance Raman spectroscopy. Participants were asked to maintain their usual diet throughout the study. Usual diet was assessed using three averaged 24-hour recalls; diet constancy was measured using food frequency questionnaires administered at baseline, Week 4, and Week 8. Repeated measures analysis of variance was used to assess the group differences in skin carotenoid status over time.
Results:
The high-dose and low-dose groups had mean±standard deviation increases in skin carotenoid status of 11,515±1,134 and 10,009±1,439 Raman intensity counts, respectively (both P values <0.001, for change in means compared with baseline) at Week 8, although they showed significant change from baseline by Week 2. The placebo group's change of 985 Raman intensity counts was not statistically significant. The difference in change between the 2 experimental groups was not significant at Week 2, 4, 6, or 8.
Conclusions:
Consumption of 30 to 120 mL (2.75 to 11 mg carotenoids) of a carotenoid-rich juice significantly increased skin carotenoid status over an 8-week period among children aged 5 to 17 years. The amount of carotenoids found in this amount of juice is equal to the amount found in approximately 23 to 92 g cooked carrots per day.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children

